SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-057373
Filing Date
2021-11-08
Accepted
2021-11-08 16:54:02
Documents
99
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_cleneinc.htm   iXBRL 10-Q 1669134
2 CERTIFICATION f10q0921ex31-1_cleneinc.htm EX-31.1 10469
3 CERTIFICATION f10q0921ex31-2_cleneinc.htm EX-31.2 10363
4 CERTIFICATION f10q0921ex32-1_cleneinc.htm EX-32.1 4843
5 CERTIFICATION f10q0921ex32-2_cleneinc.htm EX-32.2 5022
  Complete submission text file 0001213900-21-057373.txt   9024338

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE clnn-20210930.xsd EX-101.SCH 129677
7 XBRL CALCULATION FILE clnn-20210930_cal.xml EX-101.CAL 78838
8 XBRL DEFINITION FILE clnn-20210930_def.xml EX-101.DEF 457347
9 XBRL LABEL FILE clnn-20210930_lab.xml EX-101.LAB 919088
10 XBRL PRESENTATION FILE clnn-20210930_pre.xml EX-101.PRE 474917
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_cleneinc_htm.xml XML 1099513
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 211388691
SIC: 2834 Pharmaceutical Preparations